BioMarin製藥BMRN
那斯達克 · USD
64.86
+0.23
(+0.36%)
盤中 09/10 12:26 (UTC+8)
09/10 12:26 (UTC+8)
BioMarin製藥BMRN
64.86
+0.23
(+0.36%)
財務數據
損益表
- 6.49
- 7.12
- 7.46
- 7.47
- 7.45
- 8.25
- 7.76
- 8.75
- 7.66
- 9.90
- 0.41
- 9.74
- 4.73
- 0.21
- -0.29
- 10.77
- -5.97
- 12.68
- -12.39
- 29.17
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 989,708 | 766,208 | 874,565 | 776,133 | 825,410 | 745,145 | 747,313 | 745,740 | 712,029 | 648,833 |
營業成本 | 202,795 | 194,999 | 275,709 | 140,085 | 150,090 | 151,558 | 136,139 | 188,457 | 130,459 | 125,180 |
營業毛利 | 786,913 | 571,209 | 598,856 | 636,048 | 675,320 | 593,587 | 611,174 | 557,283 | 581,570 | 523,653 |
營業費用 | 675,993 | 441,569 | 643,466 | 682,740 | 398,433 | - | 449,767 | 443,390 | 461,118 | - |
研發費用 | 206,952 | 178,796 | 192,413 | 409,478 | 161,308 | 158,731 | 173,509 | 184,901 | 183,787 | 204,987 |
推銷及管理費用 | 395,549 | 258,290 | 446,207 | 268,415 | 232,279 | 206,116 | 266,607 | 253,480 | 263,032 | 225,906 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 73,492 | 4,483 | 4,846 | 4,847 | 4,846 | 4,847 | 9,651 | 5,009 | 14,299 | 14,298 |
營業利益 | 110,969 | 129,630 | -44,610 | -46,692 | 276,887 | 223,893 | 161,407 | 113,893 | 120,452 | 88,462 |
其他收入及費用 | 13,759 | 26,521 | 20,235 | 22,947 | 23,660 | 17,059 | 10,809 | 23,516 | 15,258 | 30,632 |
利息費用 | 63,295 | 14,958 | 2,778 | 2,579 | 2,679 | 2,863 | 2,577 | 2,968 | 3,574 | 3,547 |
稅前純益 | 61,384 | 141,203 | -27,153 | -26,324 | 297,868 | 238,089 | 169,639 | 134,441 | 132,136 | 105,547 |
所得稅 | 16,622 | 35,676 | 19,420 | 4,420 | 57,336 | 52,403 | 44,696 | 28,361 | 24,962 | 16,885 |
稅後純益 | 44,762 | 105,527 | -46,573 | -30,744 | 240,532 | 185,686 | 124,943 | 106,080 | 107,174 | 88,662 |
基本每股稅後盈餘(元) | 0.23 | 0.55 | -0.24 | -0.16 | 1.25 | 0.97 | 0.66 | 0.56 | 0.56 | 0.47 |
稀釋每股稅後盈餘(元) | 0.23 | 0.54 | -0.24 | -0.15 | 1.24 | 0.95 | 0.65 | 0.55 | 0.55 | 0.46 |
基本平均股數(千股) | 193423.00 | 192497.00 | 192225.00 | 192032.00 | 191907.00 | 190967.00 | 190688.00 | 190429.00 | 190114.00 | 188866.00 |
稀釋平均股數(千股) | 194467.00 | 197671.00 | 192225.00 | 192032.00 | 197091.00 | 196474.00 | 196581.00 | 197147.00 | 200505.00 | 199262.00 |
還原基本每股稅後盈餘(元) | 0.23 | 0.55 | -0.24 | -0.16 | 1.25 | 0.97 | 0.66 | 0.56 | 0.56 | 0.47 |
還原稀釋每股稅後盈餘(元) | 0.23 | 0.54 | -0.24 | -0.15 | 1.24 | 0.95 | 0.65 | 0.55 | 0.55 | 0.46 |
還原基本平均股數(千股) | 193,423 | 192,497 | 192,225 | 192,032 | 191,907 | 190,967 | 190,688 | 190,429 | 190,114 | 188,866 |
還原稀釋平均股數(千股) | 194,467 | 197,671 | 192,225 | 192,032 | 197,091 | 196,474 | 196,581 | 197,147 | 200,505 | 199,262 |
EBITDA(千元) | 222,772 | 172,117 | -5,043 | -8,953 | 317,755 | 261,659 | 194,097 | 154,474 | 159,997 | 133,942 |